Drug intelligence / Profile preview

DFD-08

Development stage: Unknown
Lead developer: Dr. Reddy's Laboratories
Modality: Small Molecules

Overview

DFD-08 is a **small-molecule dermatology candidate** reportedly developed by **Dr. Reddy's Laboratories** for **keratosis**. Publicly accessible sources identify it only at a high level as a chemical drug in skin and musculoskeletal disease, with no reliable disclosure of its exact active ingredient, molecular structure, precise mechanism of action, formulation details, or clinical pharmacology. Available evidence suggests that the program did not progress meaningfully in development and appears to be inactive or without current development progress.

Beyond the preview

Go deeper on DFD-08.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DFD-08.

Explore the full profile